PQ 463
463. Deputy Michael Healy-Rae asked the Minister for Health if he will outline the well known documented risks related to the use of Roaccutane in women of child bearing potential; and what the Health Products Regulatory Authority and the company (details supplied) are doing to eliminate risks; and if he will make a statement on the matter. [33336/15]
Introduced
29 September 2015
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
29 September 2015
Summary
463. Deputy Michael Healy-Rae asked the Minister for Health if he will outline the well known documented risks related to the use of Roaccutane in women of child bearing potential; and what the Health Products Regulatory Authority and the company (details supplied) are doing to eliminate risks; and if he will make a statement on the matter. [33336/15]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 29 September 2015
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2015-09-29/463/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2015-09-29/pq_463